Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors.
D. Karagiannis, W. Wu, A. Li, M. Hayashi, X. Chen, M. Yip, V. Mangipudi, X. Xu, F. J. Sanchez-Rivera, Y. M. Soto-Feliciano, J. Ye, T. Papagiannakopoulos, C. Lu
The paper shows that inhibiting HDACs selectively targets NRF2-activated lung adenocarcinoma by altering chromatin and metabolic pathways.
bioRxiv · Apr 24, 2023 · PreprintCancer Biology